PLoS ONE (Jan 2023)

Mid-term health-related quality of life in community-acquired bacterial meningitis survivors; the COMBAT study.

  • Claire Della Vecchia,
  • Josée Vicentia Ebah,
  • Sarah Tubiana,
  • Thomas Guimard,
  • Lionel Piroth,
  • Sylvain Jaffuel,
  • Isabelle Gorenne,
  • Bruno Mourvillier,
  • Bruno Hoen,
  • Xavier Duval,
  • Marie Préau

DOI
https://doi.org/10.1371/journal.pone.0281544
Journal volume & issue
Vol. 18, no. 3
p. e0281544

Abstract

Read online

BackgroundCommunity Acute Bacterial Meningitis (CABM) is a rare infectious disease leading to important impairments. Our aim was to describe CABM survivors' quality of life (QOL) 12 months post-CABM and to assess its associations with CABM sequelae.MethodsPatients included in the CABM COMBAT cohort were evaluated one year after the CABM episode. Data were collected by questionnaire, via phone calls with the patients. The WHOQOL-BREF was used to measure CABM survivors' QOL. Hierarchical multivariate linear regressions were performed.ResultsStudy population was composed of 284 patients. At 12 months, 53.9% (153/284) reported at least incident headache/worsening headache intensity at 12 months post-CABM, and/or incident hearing impairment, and/or unfavourable disability outcome (GOS). Unfavourable disability outcome was associated with lower physical health QOL (B = -30.35, pConclusions12 month-CABM burden is heavy. Early detection and management of CABM impairments should be performed in clinical practice as early as possible to optimize patients' psychological and psychosocial functioning.Clinicaltrial. gov identification numberNCT01730690.